Department of Pharmacology, University of Tennessee Health Science Center, 874 Union Avenue, Crowe 115, Memphis, TN 38163, USA.
Psychopharmacology (Berl). 2010 Jun;210(2):179-88. doi: 10.1007/s00213-010-1812-0. Epub 2010 Mar 16.
Relapse is one of the main challenges facing the current treatment of cocaine addiction. Understanding its neurobiological mechanism is a critical step toward developing effective anti-relapse therapies.
Emerging evidence indicates that glutamate-mediated activation of dopamine (DA) neurons in the ventral tegmental area (VTA) may be critically involved in cocaine-induced relapse to drug-seeking behavior. Activity of VTA DA neurons is modulated by multiple neurotransmitter systems including opioids, serotonin, dopamine, and acetylcholine. Recent studies demonstrated that activation of kappa-opioid receptors (kappaORs) in the rat VTA directly inhibits the activity of a subpopulation of DA neurons projecting to the prefrontal cortex (PFC) and amygdala. Because we previously showed that blockade of DA receptors in the dorsal PFC inhibits cocaine-induced reinstatement of extinguished cocaine-seeking behavior suggesting a critical role of the VTA-PFC DA circuit in this process, we tested the hypothesis that activation of kappaORs in the VTA will block cocaine-induced reinstatement in rats.
Rats were trained to self-administer intravenous cocaine (0.125 mg/infusion) under a modified fixed-ratio five schedule. After extinction of the learned behavior, the effects of activation of VTA kappaORs on cocaine-induced reinstatement were studied.
The kappaOR agonist U50 488 (0-5.6 microg/side) microinjected into the VTA dose-dependently decreased cocaine-induced reinstatement. The effects could not be explained by either a disruption of operant behavior or diffusion of the drug to the areas surrounding the VTA. Moreover, the effect was reversed by norbinaltorphimine.
The VTA DA neurons expressing functional kappaORs are critically involved in cocaine-induced reinstatement in rats.
复吸是当前可卡因成瘾治疗所面临的主要挑战之一。了解其神经生物学机制是开发有效抗复吸疗法的关键步骤。
新出现的证据表明,腹侧被盖区(VTA)中谷氨酸介导的多巴胺(DA)神经元激活可能在可卡因诱导的觅药行为复吸中起关键作用。VTA DA 神经元的活动受多种神经递质系统调节,包括阿片类物质、血清素、多巴胺和乙酰胆碱。最近的研究表明,在大鼠 VTA 中激活κ-阿片受体(κOR)可直接抑制投射到前额叶皮层(PFC)和杏仁核的 DA 神经元亚群的活性。因为我们之前的研究表明,PFC 背侧 DA 受体阻断可抑制可卡因消退后可卡因觅药行为的重新出现,提示 VTA-PFC DA 回路在此过程中起关键作用,所以我们测试了 VTA 中 κOR 激活是否会阻断大鼠可卡因诱导的复吸的假说。
大鼠接受训练以在改良的固定比率五方案下进行静脉内可卡因(0.125mg/次)自我给药。在习得行为消退后,研究了 VTA κOR 激活对可卡因诱导复吸的影响。
VTA 中 κOR 激动剂 U50488(0-5.6μg/侧)呈剂量依赖性地减少可卡因诱导的复吸。这些效应不能用操作行为的破坏或药物扩散到 VTA 周围区域来解释。此外,该效应可被 norbinaltorphimine 逆转。
表达功能性 κOR 的 VTA DA 神经元在大鼠可卡因诱导的复吸中起关键作用。